Error loading player: No playable sources found

Player size: small large

JAPANESE - Workshop Session Two - Implementation of ICH Q12 – Where Are We in Japan and Globally?

Date

December 8, 2020

This product is not available for individual purchase, but it is available as part of the following products:

Thumbnail for CMC Strategy Forum Japan 2020

CMC Strategy Forum Japan 2020

Session Chairs

F. Hoffmann-La Roche Ltd.

Akiko Ishii-Watabe

NIHS-National Institute of Health Sciences

Speakers

CDER, FDA

Yoshinori Kubodera

Chugai Pharmaceutical Co., Ltd.

GlaxoSmithKline K.K

PMDA-Pharmaceuticals and Medical Devices Agency

Wassim Nashabeh

F. Hoffmann-La Roche Ltd.

Panelist

Jean-Louis Robert

Related Products

Thumbnail for JAPANESE - CASSS & CMC Strategy Forum Japan 2020 Welcome and Introductory Comments and Workshop Session One – Recent Trends in the Regulation of Biopharmaceutical Products

JAPANESE - CASSS & CMC Strategy Forum Japan 2020 Welcome and Introductory Comments and Workshop Session One – Recent Trends in the Regulation of Biopharmaceutical Products

Thumbnail for ENGLISH - CASSS & CMC Strategy Forum Japan 2020 Welcome and Introductory Comments and Workshop Session One – Recent Trends in the Regulation of Biopharmaceutical Products

ENGLISH - CASSS & CMC Strategy Forum Japan 2020 Welcome and Introductory Comments and Workshop Session One – Recent Trends in the Regulation of Biopharmaceutical Products

Thumbnail for CASSS and CMC Strategy Forum Welcome and Introductory Comments and EFPIA MQEG Satellite Session

CASSS and CMC Strategy Forum Welcome and Introductory Comments and EFPIA MQEG Satellite Session

Thumbnail for ENGLISH - Challenges of Vaccine and Biotherapeutic Therapies for COVID-19

ENGLISH - Challenges of Vaccine and Biotherapeutic Therapies for COVID-19

In this session, the strategies/approaches to address the challenges of accelerated CMC development for new modalities will be discussed, based on recent experiences with fast-to–market of vaccines and therapeutics for COVID-19…